1.Adjustment terms and coefficients of nonlinear regression-based kurtosis-adjusted equivalent sound level method
Jinzhe LI ; Anke ZENG ; Jiarui XIN ; Yang LI ; Linjie WU ; Haiying LIU ; Yan YE ; Meibian ZHANG
Journal of Environmental and Occupational Medicine 2025;42(7):786-792
Background Noise-induced hearing loss (NIHL) is a prevalent occupational health problem in workplace settings, with non-steady noise exposure being particularly widespread. Although kurtosis-adjusted equivalent sound level (
2.A preliminary study on developing statistical distribution table of hearing threshold deviation for otologically normal Chinese adults
Linjie WU ; Yang LI ; Haiying LIU ; Anke ZENG ; Jinzhe LI ; Wei QIU ; Hua ZOU ; Meng YE ; Meibian ZHANG
Journal of Environmental and Occupational Medicine 2025;42(7):800-807
background Current assessment of noise-induced hearing loss relies on the hearing threshold statistical distribution table of ISO 7029-2017 standard (ISO 7029), which is based on foreign population data and lacks a hearing threshold distribution table derived from pure-tone audiometry data of the Chinese population, hindering accurate evaluation of hearing loss in this group. Objective To establish a statistical distribution table of hearing threshold level (HTL) for otologically normal Chinese adults and to provide a scientific basis for revising the diagnostic criteria of occupational noise-induced deafness in China. Methods A total of
3.Preparation method and preliminary functional characterization of chimeric costimulatory receptor-modified γδ T cells targeting the CD7 antigen
WANG Min1 ; ZHANG Ping1 ; YOU Fengtao2 ; XU Hanying1 ; YANG Lin1,2
Chinese Journal of Cancer Biotherapy 2025;32(11):1181-1187
[摘 要] 目的:探讨构建靶向CD7抗原的嵌合共刺激受体(CCR)并制备该受体修饰的健康供者来源γδ T细胞,以评估其对急性T淋巴细胞白血病(T-ALL)的体内与体外杀伤作用。方法:构建携带CD7-DAP10-CCR的慢病毒载体,并转导健康人外周血γδ T细胞,制备靶向CD7抗原的CCR γδ T细胞(CD7-DAP10-CCR-γδ T),所获细胞借助表达CD64、CD86和CD137L的人工抗原提呈细胞(aAPC)进行体外扩增。采用Annexin Ⅴ/7-AAD方法检测CD7-DAP10-CCR-γδ T对T-ALL细胞(Jurkat)、CD7缺陷型Jurkat细胞(CD7⁻ Jurkat)及异体健康人原代αβ T细胞的体外杀伤作用,共设置了3组效靶比(E∶T = 1∶1、1∶3和1∶10),孵育时间为18~24 h。其中,Jurkat细胞作为CD7阳性靶细胞,CD7⁻ Jurkat作为CD7阴性靶细胞以验证杀伤特异性,而异体健康人原代αβ T细胞则作为CD7阳性正常细胞对照,用于评估CD7-DAP10-CCR-γδ T细胞的脱靶效应。此外,在T-ALL荷瘤免疫缺陷小鼠体内验证药效,通过定期对荷瘤免疫缺陷小鼠进行活体成像、体质量检测及生存期观察,评估CD7-DAP10-CCR-γδ T细胞在荷瘤免疫缺陷小鼠体内的药效。结果:成功利用aAPC体外制备出CD7-DAP10-CCR-γδ T细胞,其平均扩增倍数超过10 000倍。体外杀伤实验表明,该细胞对T-ALL细胞具有较高的杀伤能力(P < 0.01),对Jurkat 细胞具有较高的毒性(P < 0.01),对CD7⁻ Jurkat细胞杀伤作用有限,而对高表达CD7的正常原代αβ T细胞基本无杀伤作用;荷瘤免疫缺陷小鼠体内药效试验结果显示,相对于对照PBS组,经CD7-DAP10-CCR-γδ T细胞治疗后,荷瘤免疫缺陷小鼠的生存期显著延长(P < 0.01)。结论:体外借助aAPC能成功制备CD7-DAP10-CCR-γδ T细胞,并且CD7-DAP10-CCR-γδ T细胞在体外、小鼠体内均对T-ALL细胞具有较强的杀伤作用,表明CD7-DAP10-CCR-γδ T细胞具备对T-ALL的治疗潜力。
4.Temporal dynamics of microglia-astrocyte interaction in neuroprotective glial scar formation after intracerebral hemorrhage
Jingwei ZHENG ; Haijian WU ; Xiaoyu WANG ; Guoqiang ZHANG ; Jia'nan LU ; Weilin XU ; Shenbin XU ; Yuanjian FANG ; Anke ZHANG ; Anwen SHAO ; Sheng CHEN ; Zhen ZHAO ; Jianmin ZHANG ; Jun YU
Journal of Pharmaceutical Analysis 2023;13(8):862-879
The role of glial scar after intracerebral hemorrhage(ICH)remains unclear.This study aimed to inves-tigate whether microglia-astrocyte interaction affects glial scar formation and explore the specific function of glial scar.We used a pharmacologic approach to induce microglial depletion during different ICH stages and examine how ablating microglia affects astrocytic scar formation.Spatial transcriptomics(ST)analysis was performed to explore the potential ligand-receptor pair in the modulation of microglia-astrocyte interaction and to verify the functional changes of astrocytic scars at different periods.During the early stage,sustained microglial depletion induced disorganized astrocytic scar,enhanced neutrophil infiltration,and impaired tissue repair.ST analysis indicated that microglia-derived insulin like growth factor 1(IGF1)modulated astrocytic scar formation via mechanistic target of rapamycin(mTOR)signaling activation.Moreover,repopulating microglia(RM)more strongly activated mTOR signaling,facilitating a more protective scar formation.The combination of IGF1 and osteopontin(OPN)was necessary and sufficient for RM function,rather than IGF1 or OPN alone.At the chronic stage of ICH,the overall net effect of astrocytic scar changed from protective to destructive and delayed microglial depletion could partly reverse this.The vital insight gleaned from our data is that sustained microglial depletion may not be a reasonable treatment strategy for early-stage ICH.Inversely,early-stage IGF1/OPN treatment combined with late-stage PLX3397 treatment is a promising therapeutic strategy.This prompts us to consider the complex temporal dynamics and overall net effect of microglia and astrocytes,and develop elaborate treatment strategies at precise time points after ICH.
5.The Genome Sequence Archive Family:Toward Explosive Data Growth and Diverse Data Types
Chen TINGTING ; Chen XU ; Zhang SISI ; Zhu JUNWEI ; Tang BIXIA ; Wang ANKE ; Dong LILI ; Zhang ZHEWEN ; Yu CAIXIA ; Sun YANLING ; Chi LIANJIANG ; Chen HUANXIN ; Zhai SHUANG ; Sun YUBIN ; Lan LI ; Zhang XIN ; Xiao JINGFA ; Bao YIMING ; Wang YANQING ; Zhang ZHANG ; Zhao WENMING
Genomics, Proteomics & Bioinformatics 2021;19(4):578-583
The Genome Sequence Archive (GSA) is a data repository for archiving raw sequence data, which provides data storage and sharing services for worldwide scientific communities. Considering explosive data growth with diverse data types, here we present the GSA family by expanding into a set of resources for raw data archive with different purposes, namely, GSA (https://ngdc.cncb.ac.cn/gsa/), GSA for Human (GSA-Human, https://ngdc.cncb.ac.cn/gsa-human/), and Open Archive for Miscellaneous Data (OMIX, https://ngdc.cncb.ac.cn/omix/). Compared with the 2017 version, GSA has been significantly updated in data model, online functionalities, and web interfaces. GSA-Human, as a new partner of GSA, is a data repository specialized in human genetics-related data with controlled access and security. OMIX, as a critical complement to the two resources mentioned above, is an open archive for miscellaneous data. Together, all these resources form a family of resources dedicated to archiving explosive data with diverse types, accepting data submissions from all over the world, and providing free open access to all publicly available data in support of worldwide research activities.
6.The Global Landscape of SARS-CoV-2 Genomes, Variants, and Haplotypes in 2019nCoVR
Song SHUHUI ; Ma LINA ; Zou DONG ; Tian DONGMEI ; Li CUIPING ; Zhu JUNWEI ; Chen MEILI ; Wang ANKE ; Ma YINGKE ; Li MENGWEI ; Teng XUFEI ; Cui YING ; Duan GUANGYA ; Zhang MOCHEN ; Jin TONG ; Shi CHENGMIN ; Du ZHENGLIN ; Zhang YADONG ; Liu CHUANDONG ; Li RUJIAO ; Zeng JINGYAO ; Hao LILI ; Jiang SHUAI ; Chen HUA ; Han DALI ; Xiao JINGFA ; Zhang ZHANG ; Zhao WENMING ; Xue YONGBIAO ; Bao YIMING
Genomics, Proteomics & Bioinformatics 2020;18(6):749-759
On January 22, 2020, China National Center for Bioinformation (CNCB) released the 2019 Novel Coronavirus Resource (2019nCoVR), an open-access information resource for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). 2019nCoVR features a comprehensive integra-tion of sequence and clinical information for all publicly available SARS-CoV-2 isolates, which are manually curated with value-added annotations and quality evaluated by an automated in-house pipeline. Of particular note, 2019nCoVR offers systematic analyses to generate a dynamic landscape of SARS-CoV-2 genomic variations at a global scale. It provides all identified variants and their detailed statistics for each virus isolate, and congregates the quality score, functional annotation,and population frequency for each variant. Spatiotemporal change for each variant can be visualized and historical viral haplotype network maps for the course of the outbreak are also generated based on all complete and high-quality genomes available. Moreover, 2019nCoVR provides a full collection of SARS-CoV-2 relevant literature on the coronavirus disease 2019 (COVID-19), including published papers from PubMed as well as preprints from services such as bioRxiv and medRxiv through Europe PMC. Furthermore, by linking with relevant databases in CNCB, 2019nCoVR offers data submission services for raw sequence reads and assembled genomes, and data sharing with NCBI. Collectively, SARS-CoV-2 is updated daily to collect the latest information on genome sequences, variants, hap-lotypes, and literature for a timely reflection, making 2019nCoVR a valuable resource for the global research community. 2019nCoVR is accessible at https://bigd.big.ac.cn/ncov/.
8.Application of MRI histogram analysis in assessment risk of medulloblastoma recurrence
Chendi ZHU ; Yong ZHANG ; Jingliang CHENG ; Ya LI ; Anke DONG ; Ruiping ZHENG
Chinese Journal of Interventional Imaging and Therapy 2017;14(8):480-483
Objective To explore the value of MRI histogram analysis in the risk assessment of medulloblastoma recur rence.Methods The data of 28 patients pathologically confirmed of medulloblastoma was analyzed retrospectively.All patients were divided into recurrent group and the non recurrent group (each n=14).The ROIs were drawn on the maximum level of enhanced MR sagittal images,and the histogram analysis were performed using the software named Mazda.The statistical analysis was performed on the histogram parameters to find out the different characteristics between the two groups,and the ROC curve was drawn to evaluate its diagnostic efficacy for recurrence of medulloblastoma.Results In all of the 9 parameters which are extracted from histogram,kurtosis had statistical significance between the 2 groups (P=0.018).The area under the ROC curve was 0.776 (P=0.018),and the sensitivity and specificity of kurtosis in the risk assessment of medulloblastoma recurrence were 64.3% and 71.4%,respectively.Conclusion MRI histogram analysis can be an important method to assess the risk of medulloblastoma recurrence.
9.Repairing allogenic thyroid cartilage defects using poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) seeded with chondrocytes
Anke SUN ; Wantong LI ; Songbo LIU ; He ZHANG ; Wei SUN ; Wei CHEN ; Chunhai SHI ; Weiwei TANG
Chinese Journal of Tissue Engineering Research 2013;(41):7181-7187
BACKGROUND:A great development has been achieved in essential research on tissue engineered cartilage. However, its real application in otolaryngology has been rarely reported. It is faced with the topic to explore the simple and convenient method of repairing laryngeal cartilage by tissue engineering technique. OBJECTIVE:To compare the effect of porous spongy poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) seeded with chondrocytes or using senior tissue engineered cartilage in repairing al ogenic thyroid cartilage defects.METHODS:Chondrocytes at passage 3 were harvested from infant rabbits within 3 days. Porous spongy poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) seeded with chondrocytes composites were made by tissue engineering technique. The chondrocyte-poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) composites were co-cultured in vitro to form junior tissue engineered cartilage. And then respectively used for repairing the thyroid cartilage defects and directly transplanted with junior tissue engineered cartilage (experimental group A, n=5), or firstly the junior tissue engineered cartilage to be implanted subcutaneously for a period of time to further maturity for relative senior tissue engineered cartilage and secondly to be transplanted (experimental group B, n=5) into adult New Zealand white rabbits. Simple poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) sponge scaffold (control group A, n=4) and chondrocyte suspensions(control group B, n=4) were used as reparative materials in defect areas as control groups. Final y, the reparative effect was respectively studied grossly and histological y at 4 weeks (experimental group B) and 8 weeks (experimental group A, control group A and control group B) after transplantation. RESULTS AND CONCLUSION:The cartilage defects were wel repaired in the experimental groups. It was smooth between the reparative area and original cartilage without dents and defects. Both were similar grossly. But few chondrocytes at interfacial region between the reparative area and original cartilage and poor matrices were observed in the experimental group A. A Few chondrocytes and more matrices were observed in the experimental group B. Inflammatory cellinfiltration was not obvious in two experimental groups. Control groups showed soft tissue of dark-red color accompanied with local concave in gross specimens. Histological examination and special staining showed there were no cartilage-like structure and secretion of matrix components. The results showed that it is possible to repair thyroid cartilage defect using junior tissue engineered cartilage directly or junior tissue engineered cartilage after in vitro implantation in al ograft rabbits with immunity, and the immunoreaction is not obvious;in the same period, the repairing effect of mature tissue engineered cartilage is better than that of junior tissue engineered cartilage. However, application of junior tissue engineered cartilage directly can save time, costs, workload and operational link, and avoid the pain from secondary skin surgery, which is one of the more practical approaches.
10.Causes of vocal cord dyscinesia and its original factors after endotracheal intubation.
Anke SUN ; Tiezheng ZHANG ; Wenyuan LIU ; Weiwei TANG ; Xiaohong GUO
Journal of Clinical Otorhinolaryngology Head and Neck Surgery 2012;26(6):248-251
OBJECTIVE:
To research the causes of postintubation vocal cord dyskinesia and its contributing factors.
METHOD:
The causes of vocal cord dyskinesia were confirmed by laryngoscope, three-dimensional spiral CT, stroboscope, and the analysis of therapy. The factors relevant to the causes of vocal cord dyskinesia were analysed based on the following elements: (1) the anatomic or pathological condition of patients or the technical skills of anesthetists. (2) emaciated or obese body and neck. (3) the age of patients. (4) the duration of endotracheal tube retention. (5) the types of operations. (6) anesthesia procedure.
RESULT:
Among 135 patients, 128 cases (94.81%) manifested arytenoid dislocation, 7 cases (5.19%) vocal cord paralysis. The study showed that the vocal cord dyskinesia associated with anatomic or pathological condition of patients and technical skills of anesthetists (with intubation difficulty) accounted for 76.30%. The patients with relative emaciated body or neck accounted for 90.62% in cases without intubation difficulty. Age had no significant analytical relationship with vocal cord dyskinesia. Prolonged intubation (endotracheal tube retention over 12 hours) was accounted for only 17.64%. The incidence of vocal cord dyskinesia was nearly 0.5% in patients underwent cardio-thoracic surgery, accounting for 59.26% of all the patients.
CONCLUSION
There are two major causes of vocal cord dyskinesia: arytenoid dislocation and vocal cord paralysis, and the rate of vocal cord dyskinesia could be reduced by the improvement of technical skill of anesthetists and/or sufficient attention to the intubation condition of patients.
Adolescent
;
Adult
;
Aged
;
Aged, 80 and over
;
Child
;
Child, Preschool
;
Female
;
Humans
;
Infant
;
Intubation, Intratracheal
;
adverse effects
;
Laryngoscopes
;
adverse effects
;
Male
;
Middle Aged
;
Vocal Cord Paralysis
;
etiology
;
physiopathology
;
Vocal Cords
;
physiopathology
;
Young Adult

Result Analysis
Print
Save
E-mail